Submission Details
| 510(k) Number | K020740 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 06, 2002 |
| Decision Date | April 16, 2002 |
| Days to Decision | 41 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K020740 is an FDA 510(k) clearance for the ROCHE ONLINE THEOPHYLLINE, a Enzyme Immunoassay, Theophylline (Class II — Special Controls, product code KLS), submitted by Roche Diagnostics Corp. (Indianapolos, US). The FDA issued a Cleared decision on April 16, 2002, 41 days after receiving the submission on March 6, 2002. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3880.
| 510(k) Number | K020740 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 06, 2002 |
| Decision Date | April 16, 2002 |
| Days to Decision | 41 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | KLS — Enzyme Immunoassay, Theophylline |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3880 |